Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review
Coronary angiography has historically served as the gold standard for diagnosis of coronary
artery disease and guidance of percutaneous coronary intervention (PCI). Adjunctive use of …
artery disease and guidance of percutaneous coronary intervention (PCI). Adjunctive use of …
Revascularization and medical therapy for chronic coronary syndromes: lessons learnt from recent trials, a literature review
V Pham, A Moroni, E Gall, A Benedetti… - Journal of Clinical …, 2023 - mdpi.com
Stable coronary artery disease (CAD) has recently been replaced by a new entity described
as chronic coronary syndrome (CCS). This new entity has been developed based on a …
as chronic coronary syndrome (CCS). This new entity has been developed based on a …
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a …
Background In the treatment of de-novo coronary small vessel disease, drug-coated
balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up …
balloons (DCBs) are non-inferior to drug-eluting stents (DESs) regarding clinical outcome up …
[HTML][HTML] Management of in-stent restenosis
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …
Treatment of coronary de novo lesions by a sirolimus-or paclitaxel-coated balloon
WAW Ahmad, AA Nuruddin, MASK Abdul Kader… - Cardiovascular …, 2022 - jacc.org
Objectives The aim of this randomized controlled trial was to investigate a novel sirolimus-
coated balloon (SCB) compared with the best investigated paclitaxel-coated balloon (PCB) …
coated balloon (SCB) compared with the best investigated paclitaxel-coated balloon (PCB) …
A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in de novo small vessels
K Ninomiya, PW Serruys, A Colombo, B Reimers… - Cardiovascular …, 2023 - jacc.org
Background There are no data comparing sirolimus-coated balloons (SCBs [MagicTouch,
Concept Medical]) to paclitaxel-coated balloons (PCBs [SeQuent Please Neo, B. Braun]) for …
Concept Medical]) to paclitaxel-coated balloons (PCBs [SeQuent Please Neo, B. Braun]) for …
Drug-coated balloon for small coronary artery disease in patients with and without high-bleeding risk in the BASKET-SMALL 2 trial
B Scheller, TT Rissanen, A Farah… - Circulation …, 2022 - Am Heart Assoc
Background: Patients at high-bleeding risk (HBR) undergoing percutaneous coronary
intervention represent a challenging patient population. The use of drug-coated balloon …
intervention represent a challenging patient population. The use of drug-coated balloon …
Assessment of paclitaxel drug-coated balloon only angioplasty in STEMI
I Merinopoulos, T Gunawardena, N Corballis… - Cardiovascular …, 2023 - jacc.org
Background Primary percutaneous coronary intervention (pPCI) with drug-eluting stents
(DES) has emerged as the standard of care, but stent-related events have persisted. Drug …
(DES) has emerged as the standard of care, but stent-related events have persisted. Drug …
Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial
A Greco, A Sciahbasi, A Abizaid… - Catheterization and …, 2022 - Wiley Online Library
Background Percutaneous coronary intervention (PCI) with drug‐eluting stent (DES)
implantation is a widely adopted strategy for the treatment of de novo coronary artery …
implantation is a widely adopted strategy for the treatment of de novo coronary artery …
Impact of diabetes on outcome with drug-coated balloons versus drug-eluting stents: the BASKET-SMALL 2 trial
J Woehrle, B Scheller, J Seeger, A Farah… - Cardiovascular …, 2021 - jacc.org
Objectives The study sought to evaluate the impact of diabetes mellitus on 3-year clinical
outcome in patients undergoing drug-coated balloon (DCB) or drug-eluting stent (DES) …
outcome in patients undergoing drug-coated balloon (DCB) or drug-eluting stent (DES) …